Navigation Links
myoscience Announces Robert Grant as Chairman of the Board
Date:1/6/2012

REDWOOD CITY, Calif., Jan. 6, 2012 /PRNewswire/ -- myoscience, Inc. of Redwood City, California is pleased to announce the appointment of Robert E. Grant as Chairman of the Board of Directors effective January 1st, 2012.  Mr. Grant was formerly Chief Executive Officer and President of Bausch & Lomb Surgical and President of Allergan Medical, a division of Allergan.  Mr. Grant has been a board member for myoscience since November 2010 and this latest announcement is a reflection of the company's continuing development as a commercial company in the global aesthetics market.

"We are pleased that Robert has agreed to take the Chairman's role at this important stage of our success.  I have the utmost respect for his strategic talent and his deep understanding of the medical device and pharmaceutical markets," said Clint Carnell, President and Chief Executive Officer of myoscience. "I would also like to thank Rich Ferrari of DeNovo Ventures.  Rich led the Board since its inception and we look forward to his continued contributions as a myoscience board member."

"myoscience's next generation, toxin-free approach to treating nerves for aesthetic and therapeutic applications represents a major advance in neuromodulation. Clint is an adept leader and manager.  He has assembled a talented management team and positioned the company for international commercial launch following recent regulatory approvals in both the EU and Canada," said Mr. Grant. 

About myoscience. myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. The myoscience technology is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions and focal cryo-treatment of tissue.  The myoscience technology has also been cleared in the US for use in pain management and general surgical use. www.myoscience.com

Contact:
Matt Franklin, 1-650-421-0671  


'/>"/>
SOURCE myoscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VirtualScopics Announces Receipt of Notice from Nasdaq
2. Breckenridge Announces Seven Paragraph IV ANDAs in 2011
3. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
4. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business
7. Tris Pharma Announces US Patent Grant Covering Platform Technology
8. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
9. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
10. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
11. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):